To compare diagnostic methods in liver disease.
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2023/02/049423
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All Cirrhosis and/or ACLF patients >18 yrs, scheduled to undergo an high risk invasive procedure with severe coagulopathy requiring correction as per risk category and degree of coagulopathy on conventional coagulation tests.
Exclusion Criteria
1.Ongoing bleeding
2.Bleeding within last 3 days
3.ACLF patients going for LT may be added in exclusion criteria
4.Antiplatelet or anticoagulant therapy (discontinued <7 d before)
5.Hemodialysis in last 3 days
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the proportion of patients requiring any blood products transfusion (i.e FFP / platelets / cryoprecipitate)Timepoint: At the time of procedure.
- Secondary Outcome Measures
Name Time Method